PFIZER INC Deferred Tax Assets, Deferred Income
PFIZER INC (PFE) had Deferred Tax Assets, Deferred Income of $300.00 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2025-02-27
- 2024-12-31: Deferred Tax Assets, Deferred Income $300.00M.
- 2023-12-31: Deferred Tax Assets, Deferred Income $471.00M.
- 2022-12-31: Deferred Tax Assets, Deferred Income $95.00M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2024-12-31 | $300.00M 10-K · filed 2025-02-27 |
| 2023-12-31 | $471.00M 10-K · filed 2025-02-27 |
| 2022-12-31 | $95.00M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |